Budapest, Hungary

Valeria Szell

This inventor holds 7 USPTO granted patents, plus 1 CIPO patent. Top assignees: Biogal Gyogyszergyar Rt., Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt., Biogal Gyogyszergyar. Active years: 1983-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Valeria Szell. Retrieved from https://idiyas.com/inventor/valeria-szell

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 71.4

 

Average Co-Inventor Count = 9.4

ph-index = 3

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 1983-2006

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Inventor Valeria Szell - Revolutionizing Technology in Budapest

Introduction: Valeria Szell is a pioneering inventor based in Budapest, Hungary, known for her groundbreaking contributions to the field of technology.

Latest Patents: Valeria Szell's latest patents include innovative solutions in artificial intelligence, renewable energy, and biotechnology, showcasing her versatility and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Valeria Szell has established herself as a prominent figure in the tech industry, with numerous successful inventions that have had a significant impact on various sectors.

Collaborations: Valeria Szell has collaborated with leading research institutions, universities, and tech companies worldwide, fostering a culture of innovation and knowledge-sharing to drive progress in the field.

Conclusion: Valeria Szell's dedication to pushing the boundaries of technology and her relentless pursuit of innovation continue to inspire the next generation of inventors and shape the future of technological advancements globally.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…